SCHEMBL7962445

SCHEMBL7962445

OC1(c2cncc3ccccc23)CCN(CCCOc2cccc3[nH]ccc23)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.42
SLC6A4 P31645 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
HRH3 Q9Y5N1 7/20 0.41
DRD3 P35462 1/20 0.41
HTR2A P28223 2/20 0.41
HTR7 P34969 2/20 0.41
HTR6 P50406 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SLC6A1 P30531 1/20 0.40
SLC6A12 P48065 1/20 0.40
SLC6A11 P48066 1/20 0.40
SLC6A13 Q9NSD5 1/20 0.40
MCL1 Q07820 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
DRD4 P21917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6621730 0.90 TDP1 (0.48) HTR1ASLC6A4TDP1HRH3DRD3
SCHEMBL7965744 0.85 HTR1A (0.36) HTR1ASLC6A4DRD3HTR2AHTR7
SCHEMBL7965737 0.85 HTR1A (0.41) HTR1ASLC6A4DRD3MCL1DRD4
SCHEMBL7965741 0.85 HTR1A (0.54) HTR1ASLC6A4
SCHEMBL7967101 0.81 HTR1A (0.40) HTR1ASLC6A4TDP1HRH3DRD3
SCHEMBL7883032 0.80 CCR1 (0.48) HTR1ASLC6A4TDP1HRH3DRD3
SCHEMBL7963782 0.80 HTR1A (0.47) HTR1ASLC6A4TDP1HRH3ADRA1D
SCHEMBL7887491 0.77 HTR1A (0.44) HTR1ASLC6A4HRH3DRD3HTR2A
Oxalic Acid SCHEMBL7966039 0.77 HTR1A (0.46) HTR1ASLC6A4HRH3DRD3HTR2A
Oxalic Acid SCHEMBL7966080 0.77 KDM4E (0.54) HRH3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed